Inhibits the NLRP3 inflammasome, a driver of chronic inflammation in diabetes, cardiovascular disease, neurodegeneration, and gout.
View the study (preclinical) →Endogenous HDAC inhibitor; reduces vascular senescence via Oct4 and mTOR inhibition.
View the study (preclinical) →Alternative brain energy source when glucose utilization is impaired (Alzheimer's as type 3 diabetes).
⏱ 3 min read
Beta-hydroxybutyrate is the molecule your body makes when there is not enough glucose available and it needs to find an alternative energy source for the brain and other tissues, and what research in recent years has revealed is that this ketone body is not simply an emergency fuel but a signaling molecule with a broad and surprising influence on processes as fundamental as gene regulation, inflammation control, cellular senescence, and longevity; that is, BHB does not merely feed cells when sugar is scarce, it tells them to activate survival programs that would otherwise remain dormant.
BHB is produced by the liver from short-chain fatty acids during fasting, intense exercise, or ketogenic diets, and can be converted into acetyl-CoA to enter the Krebs cycle and generate ATP; but its role as a signaling molecule may be as important as, or more important than, its energy role: BHB is an inhibitor of histone deacetylases or HDACs, a class of enzymes that regulate the packaging of DNA and, therefore, which genes are expressed at a given moment; by inhibiting HDACs, BHB acts in a way similar to some drugs used in oncology and neurology, opening up chromatin and facilitating the transcription of genes that would otherwise be silenced.
One of the best-documented properties of BHB is its ability to inhibit the NLRP3 inflammasome, an intracellular protein complex that, when persistently and uncontrollably activated, is a central driver of the chronic low-grade inflammation underlying conditions such as type 2 diabetes, cardiovascular disease, neurodegenerative diseases, and gout; studies in animal models have shown that both ketogenic diets and direct administration of BHB reduce NLRP3 activation and the secretion of proinflammatory cytokines such as interleukin-1 beta, although data from human trials with ketone supplements have shown paradoxical results in some inflammatory markers, which underscores the need for more research.
One of the most intriguing findings about BHB in recent years is its effect on cellular senescence, the process by which damaged cells stop dividing but remain in tissues, secreting inflammatory molecules that impair neighboring cells; studies in animal models and cell cultures have shown that both fasting and direct administration of BHB reduce senescence in vascular cells through activation of the transcription factor Oct4, a protein associated with the regenerative capacity of stem cells, and the activation of signaling pathways such as mTOR inhibition and AMPK activation, which are two of the most important regulators of cellular longevity.
Practical ways to increase BHB levels include ketogenic diets, defined as those in which carbohydrate intake is low enough, typically below 10 percent of total calories, to induce hepatic ketone production; intermittent fasting, especially fasting of more than 16 hours, which depletes hepatic glycogen stores; physical exercise, which consumes muscle and liver glycogen and increases ketogenesis during and after exertion; and supplementation with exogenous ketones, available in the form of ketone salts and ketone monoesters, although the evidence for their specific benefits in healthy humans remains incipient and requires more controlled trials.
Information, not medical advice. Scientific evidence reflects the quality of the studies.